APA

Zhou B., Zuo Y., Li B., Wang H., Liu H., Wang X., Qiu X., Hu Y., Wen S., Du J. & Bu X. (20140401). Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells. : Molecular cancer therapeutics.

Chicago

Zhou Binhua, Zuo Yinglin, Li Baojian, Wang Hao, Liu Hao, Wang Xianfeng, Qiu Xu, Hu Yun, Wen Shijun, Du Jun and Bu Xianzhang. 20140401. Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells. : Molecular cancer therapeutics.

Harvard

Zhou B., Zuo Y., Li B., Wang H., Liu H., Wang X., Qiu X., Hu Y., Wen S., Du J. and Bu X. (20140401). Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells. : Molecular cancer therapeutics.

MLA

Zhou Binhua, Zuo Yinglin, Li Baojian, Wang Hao, Liu Hao, Wang Xianfeng, Qiu Xu, Hu Yun, Wen Shijun, Du Jun and Bu Xianzhang. Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells. : Molecular cancer therapeutics. 20140401.